HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C P Chiang Selected Research

HLA Te antigen

4/2000Association of HLA-te22 antigen with anti-nuclear antibodies in Chinese patients with erosive oral lichen planus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C P Chiang Research Topics

Disease

7Oral Submucous Fibrosis
08/2002 - 03/2000
4Oral Lichen Planus
05/2007 - 04/2000
4Aphthous Stomatitis (Aphthous Ulcer)
10/2001 - 04/2000
3Necrosis
05/2007 - 04/2001
3Squamous Cell Carcinoma of Head and Neck
10/2001 - 09/2000
3Neoplasms (Cancer)
07/2001 - 01/2001
2Inflammation (Inflammations)
09/2005 - 06/2005
2Adenoid Cystic Carcinoma (Cylindroma)
07/2001 - 04/2001
2Mucocele
07/2001 - 04/2001
2Carcinogenesis
01/2001 - 09/2000
2Bone Resorption
06/2000 - 02/2000
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2000 - 02/2000
1Pernicious Anemia
05/2013
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
05/2013
1Ulcer
06/2005
1Genetic Predisposition to Disease (Genetic Predisposition)
08/2002
1Mouth Neoplasms (Oral Cancer)
12/2001
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2001
1Oral Leukoplakia
10/2001
1Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
07/2001
1Pulpitis
03/2001
1Dental Caries (Decay, Dental)
03/2001
1Disease Progression
07/2000
1Oral Ulcer (Mouth Ulcer)
04/2000
1Transitional Cell Carcinoma
02/2000
1Bone Diseases (Bone Disease)
02/2000

Drug/Important Bio-Agent (IBA)

6AntibodiesIBA
05/2013 - 03/2000
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2007 - 03/2001
4CytokinesIBA
06/2005 - 11/2001
3HLA Antigens (Human Leukocyte Antigens)IBA
08/2001 - 04/2000
2Levamisole (Decaris)FDA Link
05/2007 - 10/2001
2Interleukin-8 (Interleukin 8)IBA
09/2005 - 06/2005
2ProstaglandinsIBA
09/2005 - 03/2001
2Interleukin-6 (Interleukin 6)IBA
09/2005 - 06/2005
2AutoantibodiesIBA
08/2002 - 04/2000
2EnzymesIBA
10/2001 - 07/2000
2Proteins (Proteins, Gene)FDA Link
01/2001 - 03/2000
1IronIBA
05/2013
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2005
1InterleukinsIBA
06/2005
1CollagenIBA
12/2001
1AntigensIBA
10/2001
1HLA-DR Antigens (HLA-DR)IBA
08/2001
1Transforming Growth Factor alpha (TGF-alpha)IBA
07/2001
1Epidermal Growth Factor (EGF)IBA
04/2001
1FluoridesIBA
03/2001
1Tissue Inhibitor of Metalloproteinase-1IBA
03/2001
1AcidsIBA
03/2001
1Messenger RNA (mRNA)IBA
03/2001
1Dinoprostone (PGE2)FDA Link
03/2001
1Proto-Oncogene Proteins c-mdm2IBA
01/2001
1Tumor Suppressor Protein p53IBA
01/2001
1Arecoline (Arecolin)IBA
09/2000
1Interleukin-2 (IL2)IBA
07/2000
1Interleukin-2 Receptors (IL 2 Receptor)IBA
07/2000
1Monoclonal AntibodiesIBA
07/2000
1Proliferating Cell Nuclear Antigen (PCNA)IBA
07/2000
1Transforming Growth Factor beta (TGF-beta)IBA
06/2000
1Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2000
1Anti-Idiotypic AntibodiesIBA
04/2000
1HLA-DR3 Antigen (HLA DR3 Antigen)IBA
04/2000
1HLA Te antigenIBA
04/2000
1Saline SolutionIBA
02/2000
1Calcitriol (Calcijex)FDA LinkGeneric
02/2000
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
02/2000
1Calcitonin Receptors (Calcitonin Receptor)IBA
02/2000
1Mitoxantrone (Novantrone)FDA LinkGeneric
02/2000

Therapy/Procedure

1Oral Administration
11/2001
1Solid-State Lasers
03/2001
1Lasers (Laser)
03/2001
1Aftercare (After-Treatment)
03/2001
1Pelvic Exenteration
04/2000
1Chemoprevention
02/2000